MENU

OCS Oculis Holding AG Forecast, Technical & Fundamental Analysis

Oculis Holding AG is a biopharmaceutical company purposefully driven to save sight and improve eye care... Show more

OCS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
View a ticker or compare two or three
OCS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

OCS is expected to report earnings to rise 152.69% to -40 cents per share on November 05

Oculis Holding AG OCS Stock Earnings Reports
Q3'26
Est.
$-0.40
Q2'26
Beat
by $0.23
Q1'26
Beat
by $0.08
Q3'25
Beat
by $0.14
Q2'25
Missed
by $0.03
The last earnings report on August 06 showed earnings per share of -15 cents, beating the estimate of -39 cents. With 105.00K shares outstanding, the current market capitalization sits at 715.20M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Details
Industry
N/A
Address
Bahnhofstrasse 20
Phone
+41 417113960
Employees
60
Web
https://www.oculis.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SPMIX30.210.08
+0.27%
Shelton S&P Midcap Index Investor
CDDYX42.010.01
+0.02%
Columbia Dividend Income Inst3
IAUYX29.55N/A
N/A
Invesco Dividend Income Y
MFWLX18.49N/A
N/A
MFS Global Total Return R6
HNASX19.62N/A
N/A
Homestead Growth

OCS and Stocks

Correlation & Price change

A.I.dvisor tells us that OCS and JSPR have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that OCS and JSPR's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OCS
1D Price
Change %
OCS100%
-0.08%
JSPR - OCS
33%
Poorly correlated
+11.72%
FTH - OCS
32%
Poorly correlated
+5.01%
GRI - OCS
30%
Poorly correlated
+29.41%
PRAX - OCS
29%
Poorly correlated
+1.01%
PDSB - OCS
28%
Poorly correlated
-64.87%
More
Oculis Holding AG (OCS) stock Forecast, Price Targets and Analysts Predictions - Tickeron.com